EP1749531
Use of an oral suspension comprising megestrol acetate for the treatment of bronchial asthma
:
EP einkaleyfi: Þýðing ekki lögð inn:
3.8.2005:
22.7.2015:
05016875.6
:
2.8.2025
:
Use of an oral suspension comprising megestrol acetate for the treatment of bronchial asthma
3.8.2005
22.7.2015
:
Par Pharmaceutical, Inc.:
300 Tice Boulevard, 07677, Woodcliff Lake, NJ, US
:
Anker, Stefan:
Berlin, DE
:
Springer, Jochen:
Falkensee, DE
:
A61K 31/57, A61P 11/06, A61K 45/06, A61K 9/10, A61K 9/00